Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan
· Delayed Price · Currency is TWD 139.50
-1.00 (-0.71%)
Mar 9, 2026, 1:30 PM CST
TPEX:3218 Revenue
Universal Vision Biotechnology had revenue of 1.02B TWD in the quarter ending September 30, 2025, a decrease of -5.08%. This brings the company's revenue in the last twelve months to 4.21B, up 0.62% year-over-year. In the year 2024, Universal Vision Biotechnology had annual revenue of 4.23B with 3.58% growth.
Revenue (ttm)
4.21B
Revenue Growth
+0.62%
P/S Ratio
2.81
Revenue / Employee
10.48M
Employees
401
Market Cap
11.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 4.23B | 146.05M | 3.58% |
| Dec 31, 2023 | 4.08B | 588.20M | 16.83% |
| Dec 31, 2022 | 3.49B | 862.26M | 32.76% |
| Dec 31, 2021 | 2.63B | 578.66M | 28.18% |
| Dec 31, 2020 | 2.05B | 634.16M | 44.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 15.63B |
| Caliway Biopharmaceuticals | 34.99M |
| Heron Neutron Medical | 5.53M |
| Lotus Pharmaceutical | 18.66B |
| Great Tree Pharmacy | 18.90B |
| Handa Pharmaceuticals | 1.62B |
| TaiDoc Technology | 4.34B |
| Medigen Vaccine Biologics | 594.96M |